KCT0008709尚未招募Unknown
A multi-center, single-arm clinical study for the efficacy and safety of '10THERMA' on tissue coagulation and skin rejuvenation
Korean Society for Laser Medicine and Sugery0 个研究点目标入组 31 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30(Year) 至 70(Year)（—）
- 性别
- All
入选标准
- •1) Adults between the ages of 30 and 70
- •2) Those who meet all of the following wrinkle scales
- •- Those who want temporary improvement of both crow's feet and those who have a resting (expressionless) Crow's Feet Grading Scale of 1-2 points
- •- Those who want temporary improvement of cheek wrinkle and have a cheek line grading scale of 1-2 points
- •3) Those who agree to stop all dermatological treatments or treatments, including wrinkle improvement of the facial area, during this clinical trial
- •4) Those who agree to take a picture of the facial area, including the eye area
- •5) Those who voluntarily decide to participate in this clinical trial and agree to the subject consent form in writing
排除标准
- •1) Those who have undergone cosmetic treatment such as laser, phototherapy, or surgery on the face within the last 6 months, or have undergone filler treatment using collagen, hyaluronic acid filler, or other materials
- •2) Those who have received radiotherapy in the facial area or have a history of chemotherapy and a history of malignant tumors
- •3) Those who have a history of infection, dermatitis, rash and heat-stimulated diseases such as herpes simplex and herpes zoster (including severe acne, fever or light, various allergies to beauty products, etc.), and those who have used steroid drugs
- •4) Those who have a history of keloid scarring, hypertrophic scarring, and abnormal wound healing
- •5) Those who have used whitening agents (Hydroquinone, Tranexamic acid, etc.), Isotretinoid (or Retinoid), light-sensitive drugs, and steroid drugs within the last 6 months
- •6) Women who are pregnant and breastfeeding (those who plan to become pregnant during the clinical trial or do not agree to appropriate contraceptive methods)
- •7) Other investigators judged to be inappropriate for this clinical trial
研究者
相似试验
招募中
Unknown
PASSAGE Clinical TrialJPRN-jRCT2032220496Kawahara Kazuo51
进行中（未招募）
3 期
Study on the endovascular visualization capability of an OFDI catheterJPRN-jRCT2052190025Hirata Ken-ichi20
进行中（未招募）
1 期
A clinical study, conducted in several sites in Belgium, investigating the administration at patient's home of the new subcutaneous formulation of the drug trastuzumab for treating patients suffering from a type of breast cancer at early stage, called HER2-positive early breast cancer.TO INVESTIGATE THE AT HOME ADMINISTRTATION OF TRASTUZUMAB SUBCUTANEOUS VIAL FOR THE TREATMENT OF PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER.EUCTR2013-000123-13-BEV ROCHE SA100
招募中
3 期
A study to investigate the pharmacokinetics and safety of dupilumab in participants >=2 years to < 12 years of age with uncontrolled chronic spontaneous urticaria (CSU) or chronic inducible cold urticaria (CICU)JPRN-jRCT2031220733Tanaka Tomoyuki24
已完成
不适用
Prospective Multi-Center, Single Arm Study of the Shockwave Coronary Rx Lithoplasty® System in Coronary Arteriesarterial stenosisstenotic coronary arteries10011082NL-OMON43455Shockwave Medical Inc.15